Search

everythinglearnresearchcommunity

for

Search:↓

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Platelet-rich plasma might help with hair growth and skin conditions, but more research is needed to prove its effectiveness and safety.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Skin problems are very common in people with end-stage kidney disease.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Cold atmospheric plasma is a promising and safe treatment for various skin conditions.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Skin problems can be linked to sexual abuse, requiring careful medical and psychological evaluation.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Bioactive glasses help heal skin wounds by promoting tissue repair and preventing infections.